MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Second Quarter 2011 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China August8, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2011. Highlights for Second Quarter 2011 Net revenues were $217.3 million,]

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2011 Financial Results STYLE=”font-family:Times

[Mindray Announces Second Quarter 2011 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China August8, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2011. Highlights for Second Quarter 2011 Net revenues were $217.3 million,]

MR [Mindray Medical International] SC 13G: (Original Filing)

[Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parentmpany Not Applicable Item 8. Identification and Classification of Members of the Not Applicable Item 9. Notice of Dissolution of Not Applicable Item 10. Certification By signing below I certify that, to the best of my knowledge and]

MR [Mindray Medical International] SC 13G: Item 7. Identification and Classification of the Subsidiary

[Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parentmpany Not Applicable Item 8. Identification and Classification of Members of the Not Applicable Item 9. Notice of Dissolution of Not Applicable Item 10. Certification By signing below I certify that, to the best of my knowledge and]

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Announces Management Changes -Chief Financial Officer Resigns - -Vice President of Sinovac Named Interim Chief Financial Officer BEIJING, August 5, 2011 -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today the resignation of Jacob Chik Keung Ho, its Chief Financial Officer, for personal reasons. The Company has initiated an executive search for] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD. August 5]

By | 2016-03-24T01:47:04+00:00 August 8th, 2011|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Announces Management Changes -Chief Financial Officer Resigns

[Sinovac Announces Management Changes -Chief Financial Officer Resigns - -Vice President of Sinovac Named Interim Chief Financial Officer BEIJING, August 5, 2011 -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today the resignation of Jacob Chik Keung Ho, its Chief Financial Officer, for personal reasons. The Company has initiated an executive search for] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD. August 5]

By | 2016-03-24T01:48:23+00:00 August 8th, 2011|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

SOL [ReneSola] 6-K: (Original Filing)

[ReneSola Ltd Announces Notice of Annual General Meeting JIASHAN, China, August 8, 2011 http://www.renesola.com Copies of the notice of AGM, proxy form and poll card are available on ReneSola’s investor relations website at AGM Resolutions The following resolutions to be proposed at the AGM will require a simple majority of the votes cast by the shareholders present in person or] [NOTICE OF ANNUAL GENERAL MEETING Company Notice is hereby given that the Annual General Meeting of ReneSola Ltd (the " 1. To receive, consider and approve the financial statements for the year ended 31 December 2010, together with the reports of the auditors thereon. 2. To re-elect Mr. Xianshou Li as a director of the Company, who is retiring by] [RENESOLA LTD No. 8 Baoqun Road, YaoZhuang Jiashan, Zhejiang 314117 People’s Republic of China x ¨ Form 20-F ¨ x Yes N/A 82- ____ RENESOLA LTD Xianshou Li Xianshou Li Chief Executive Officer]

By | 2016-03-27T12:36:53+00:00 August 8th, 2011|Categories: Chinese Stocks, SEC Original, SOL|Tags: , , , , , |0 Comments

ACTS [Actions Semiconductor] CORRESP: (Original Filing)

[August 8, 2011 VIA EDGAR Division of Corporate Finance 100 F Street, N.E. Attention: Brian Cascio, Accounting Branch Chief Kristin Lochhead Jay Mumford Geoff Kruczek Re: Actions Semiconductor Co., Ltd. Form 20-F for the fiscal year ended December 31, 2010 Filed April 22, 2011 File No. 000-51604 Ladies and Gentlemen: Company Commission Comment Letter Actions Semiconductor Co., Ltd. (the “]

By | 2016-03-27T22:57:22+00:00 August 8th, 2011|Categories: ACTS, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

ACTS [Actions Semiconductor] CORRESP: August 8, 2011 VIA EDGAR Division of Corporate

[August 8, 2011 VIA EDGAR Division of Corporate Finance 100 F Street, N.E. Attention: Brian Cascio, Accounting Branch Chief Kristin Lochhead Jay Mumford Geoff Kruczek Re: Actions Semiconductor Co., Ltd. Form 20-F for the fiscal year ended December 31, 2010 Filed April 22, 2011 File No. 000-51604 Ladies and Gentlemen: Company Commission Comment Letter Actions Semiconductor Co., Ltd. (the “]

By | 2016-03-27T22:58:25+00:00 August 8th, 2011|Categories: ACTS, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar